Loading...
Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib
This study is an unbiased genomic screen to obtain functional targets for increased effectiveness of dasatinib in pancreatic cancer. Dasatinib, a multi-targeted tyrosine kinase inhibitor, is used in clinical trials for treatment of pancreatic cancer; however, intrinsic and acquired resistance often...
Saved in:
Published in: | J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Ivyspring International Publisher
2018
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299388/ https://ncbi.nlm.nih.gov/pubmed/30588262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.25138 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|